Received Jan 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
stored at 35.79F for 72 hours due to refrigerator malfunction over the weekend, Patients were administered vaccines prior to calling excursion; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. Co-suspect products included HAV (Havrix) for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis, DTPa (Reduced antigen) (Boostrix) for prophylaxis and DTPa (Infanrix) for prophylaxis. On an unknown date, the patient received Menveo, Havrix, Kinrix, Boostrix and Infanrix. On an unknown date, an unknown time after receiving Menveo, Havrix, Kinrix, Boostrix and Infanrix, the patient experienced incorrect storage of drug (Verbatim: stored at 35.79F for 72 hours due to refrigerator malfunction over the weekend, Patients were administered vaccines prior to calling excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-JAN-2026 The reporter requested the stability data for Menveo (1-vial), Havrix, Kinrix, Boostrix, Infanrix stored at 35.79F for 72hours due to refrigerator malfunction over the weekend. No prior excursions. The patients were administered vaccines prior to calling excursion into GSK. The batch number was not provided upon follow- up with the reporter.